Therapeutic drug monitoring of teriflunomide: do plasma concentrations predict response to leflunomi...
Therapeutic drug monitoring of teriflunomide: do plasma concentrations predict response to leflunomide in patients with rheumatoid arthritis?
About this item
Full title
Author / Creator
Publisher
Berlin: Walter de Gruyter GmbH
Journal title
Language
English
Formats
Publication information
Publisher
Berlin: Walter de Gruyter GmbH
Subjects
More information
Scope and Contents
Contents
Leflunomide is a commonly used treatment for rheumatoid arthritis. It acts by inhibiting dihydroorotate dehydrogenase through its active metabolite teriflunomide. The objective of the study was to investigate the relation between plasma-concentration of teriflunomide and disease-activity in rheumatoid arthritis.Data were collected from patients wit...
Alternative Titles
Full title
Therapeutic drug monitoring of teriflunomide: do plasma concentrations predict response to leflunomide in patients with rheumatoid arthritis?
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2786539627
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2786539627
Other Identifiers
ISSN
0792-5077
E-ISSN
2191-0162
DOI
10.1515/dmpt-2021-0236
